There are many immune-mediated dermatologic diseases and an expanding list of therapeutic targets. As new drugs are developed to block increasingly specific pathways, receptors, and ligands, can we...
No takes yet. Share an insight, caveat, or question.
Shaffer et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: